Scholars Central

Conference abstractPublished 11 May 2017

Unappreciated role of type-I interferon signaling in HBV and HCV persistent infections and resistance to interferon therapy

Authors: Limin Chen

University of Toronto, Canada; Peking Union Medical College, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Activation of the type-I interferon (IFN) signaling pathway poses the first line of defense against many virus infections, including HCV and HBV. With the activation of the Jak/STAT signaling leading to the increased expression of several hundred interferonstimulated genes (ISGs) in the liver microenvironment, an anti-viral state was established and the virus replication was suppressed. However, over-activation of the type-I IFN signaling may actually benefit virus leading to its persistent infection. High throughput gene expression profiling identified 18 differentially-expressed hepatic genes between treatment responders (Rs) and non-responders (NRs) to IFN treatment of patients chronically infected with HCV. Many of these genes are ISGs and they all showed higher expression levels in the pretreatment liver tissues of NRs, indicating that over-activation of type I IFN signaling contributes to treatment nonresponse leading to persistent infection. Similar findings were observed in chronic HBV infection. Mechanistically, some of these ISGs, such as ISG15 and ISG16 stimulated HCV replication and blunted IFN anti-HCV activity. In line with our observations, studies from other labs demonstrated that blocking IFN signaling facilitated viral clearance in chronic infections, such as in LCMV. All these data point out that type-I IFN signaling is a âÂ?Â?double-edgedâÂ? sword, while activation of this pathway is indeed necessary to control viral spread, over-activation actually benefits virus to facilitate its persistent infection. Detailed molecular mechanisms warrant further investigation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Virology & Mycology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalVirology & Mycology
  • SubjectInfectious Diseases
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Limin Chen”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels